A case of subretinal neovascularization treated with intravitreal ranibizumab in a patient with idiopathic juxtafoveal retinal telangiectasis

Dimitrios Karagiannis1, Ilias Georgalas2, Ioannis Ladas2, Parikakis Eustratios1, Panagiotis Mitropoulos11Second Department of Ophthalmiatrion Eye Hospital, NHS, Athens, Greece; 2Department of Ophthalmology, “G.Genimatas” General Hospital, Athens, GreeceAbstract: A 65-year-old lad...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Dimitrios Karagiannis, Ilias Georgalas, Ioannis Ladas, Parikakis Eustratios, Panagiotis Mitropoulos
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2008
Materias:	choroidal neovascularization ranizumab idiopathic juxtafoveal retinal telangiectasis Geriatrics RC952-954.6
Acceso en línea:	https://doaj.org/article/fb8da5c43127472d9b2bbfd02f2f3194
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:fb8da5c43127472d9b2bbfd02f2f3194
record_format	dspace
spelling	oai:doaj.org-article:fb8da5c43127472d9b2bbfd02f2f31942021-12-02T01:51:47ZA case of subretinal neovascularization treated with intravitreal ranibizumab in a patient with idiopathic juxtafoveal retinal telangiectasis1178-1998https://doaj.org/article/fb8da5c43127472d9b2bbfd02f2f31942008-12-01T00:00:00Zhttps://www.dovepress.com/a-case-of-subretinal-neovascularization-treated-with-intravitreal-rani-peer-reviewed-article-CIAhttps://doaj.org/toc/1178-1998Dimitrios Karagiannis1, Ilias Georgalas2, Ioannis Ladas2, Parikakis Eustratios1, Panagiotis Mitropoulos11Second Department of Ophthalmiatrion Eye Hospital, NHS, Athens, Greece; 2Department of Ophthalmology, “G.Genimatas” General Hospital, Athens, GreeceAbstract: A 65-year-old lady presented with decreased vision in her left eye (LE). Best corrected visual acuity (BCVA) was 1/20. Complete examination showed idiopathic juxtafoveal retinal telangiectasis associated with subretinal neovascularization and she was treated with intravitreal ranibizumab every month for three months in the LE. After four months, her BCVA increased to 3/10. Fluorescein angiography (FA) showed minimal leakage and optical coherence tomography (OCT) confirmed absence of intra- or subretinal fluid in the macula. Examinations were repeated monthly for another 12 months and showed no recurrence. Intravitreal ranibizumab showed promising results for subretinal neovascularization due to idiopathic juxtafoveal retinal telangiectasis. A prospective study with large series of patients and controls may be necessary in order to determine the effectiveness of this treatment.Keywords: idiopathic juxtafoveal retinal telangiectasis, ranibizumab, subretinal neovascularizationDimitrios KaragiannisIlias GeorgalasIoannis LadasParikakis EustratiosPanagiotis MitropoulosDove Medical Pressarticlechoroidal neovascularizationranizumabidiopathic juxtafoveal retinal telangiectasisGeriatricsRC952-954.6ENClinical Interventions in Aging, Vol Volume 4, Pp 63-65 (2008)
institution	DOAJ
collection	DOAJ
language	EN
topic	choroidal neovascularization ranizumab idiopathic juxtafoveal retinal telangiectasis Geriatrics RC952-954.6
spellingShingle	choroidal neovascularization ranizumab idiopathic juxtafoveal retinal telangiectasis Geriatrics RC952-954.6 Dimitrios Karagiannis Ilias Georgalas Ioannis Ladas Parikakis Eustratios Panagiotis Mitropoulos A case of subretinal neovascularization treated with intravitreal ranibizumab in a patient with idiopathic juxtafoveal retinal telangiectasis
description	Dimitrios Karagiannis1, Ilias Georgalas2, Ioannis Ladas2, Parikakis Eustratios1, Panagiotis Mitropoulos11Second Department of Ophthalmiatrion Eye Hospital, NHS, Athens, Greece; 2Department of Ophthalmology, “G.Genimatas” General Hospital, Athens, GreeceAbstract: A 65-year-old lady presented with decreased vision in her left eye (LE). Best corrected visual acuity (BCVA) was 1/20. Complete examination showed idiopathic juxtafoveal retinal telangiectasis associated with subretinal neovascularization and she was treated with intravitreal ranibizumab every month for three months in the LE. After four months, her BCVA increased to 3/10. Fluorescein angiography (FA) showed minimal leakage and optical coherence tomography (OCT) confirmed absence of intra- or subretinal fluid in the macula. Examinations were repeated monthly for another 12 months and showed no recurrence. Intravitreal ranibizumab showed promising results for subretinal neovascularization due to idiopathic juxtafoveal retinal telangiectasis. A prospective study with large series of patients and controls may be necessary in order to determine the effectiveness of this treatment.Keywords: idiopathic juxtafoveal retinal telangiectasis, ranibizumab, subretinal neovascularization
format	article
author	Dimitrios Karagiannis Ilias Georgalas Ioannis Ladas Parikakis Eustratios Panagiotis Mitropoulos
author_facet	Dimitrios Karagiannis Ilias Georgalas Ioannis Ladas Parikakis Eustratios Panagiotis Mitropoulos
author_sort	Dimitrios Karagiannis
title	A case of subretinal neovascularization treated with intravitreal ranibizumab in a patient with idiopathic juxtafoveal retinal telangiectasis
title_short	A case of subretinal neovascularization treated with intravitreal ranibizumab in a patient with idiopathic juxtafoveal retinal telangiectasis
title_full	A case of subretinal neovascularization treated with intravitreal ranibizumab in a patient with idiopathic juxtafoveal retinal telangiectasis
title_fullStr	A case of subretinal neovascularization treated with intravitreal ranibizumab in a patient with idiopathic juxtafoveal retinal telangiectasis
title_full_unstemmed	A case of subretinal neovascularization treated with intravitreal ranibizumab in a patient with idiopathic juxtafoveal retinal telangiectasis
title_sort	case of subretinal neovascularization treated with intravitreal ranibizumab in a patient with idiopathic juxtafoveal retinal telangiectasis
publisher	Dove Medical Press
publishDate	2008
url	https://doaj.org/article/fb8da5c43127472d9b2bbfd02f2f3194
work_keys_str_mv	AT dimitrioskaragiannis acaseofsubretinalneovascularizationtreatedwithintravitrealranibizumabinapatientwithidiopathicjuxtafovealretinaltelangiectasis AT iliasgeorgalas acaseofsubretinalneovascularizationtreatedwithintravitrealranibizumabinapatientwithidiopathicjuxtafovealretinaltelangiectasis AT ioannisladas acaseofsubretinalneovascularizationtreatedwithintravitrealranibizumabinapatientwithidiopathicjuxtafovealretinaltelangiectasis AT parikakiseustratios acaseofsubretinalneovascularizationtreatedwithintravitrealranibizumabinapatientwithidiopathicjuxtafovealretinaltelangiectasis AT panagiotismitropoulos acaseofsubretinalneovascularizationtreatedwithintravitrealranibizumabinapatientwithidiopathicjuxtafovealretinaltelangiectasis AT dimitrioskaragiannis caseofsubretinalneovascularizationtreatedwithintravitrealranibizumabinapatientwithidiopathicjuxtafovealretinaltelangiectasis AT iliasgeorgalas caseofsubretinalneovascularizationtreatedwithintravitrealranibizumabinapatientwithidiopathicjuxtafovealretinaltelangiectasis AT ioannisladas caseofsubretinalneovascularizationtreatedwithintravitrealranibizumabinapatientwithidiopathicjuxtafovealretinaltelangiectasis AT parikakiseustratios caseofsubretinalneovascularizationtreatedwithintravitrealranibizumabinapatientwithidiopathicjuxtafovealretinaltelangiectasis AT panagiotismitropoulos caseofsubretinalneovascularizationtreatedwithintravitrealranibizumabinapatientwithidiopathicjuxtafovealretinaltelangiectasis
_version_	1718402875798847488

A case of subretinal neovascularization treated with intravitreal ranibizumab in a patient with idiopathic juxtafoveal retinal telangiectasis

Ejemplares similares